PAVMED INC
NASDAQ: PAVM (PAVmed Inc.)
Kemas kini terakhir: 13 jam lalu8.67
-0.27 (-3.02%)
| Penutupan Terdahulu | 8.94 |
| Buka | 8.94 |
| Jumlah Dagangan | 15,328 |
| Purata Dagangan (3B) | 1,058,535 |
| Modal Pasaran | 7,987,541 |
| Harga / Jualan (P/S) | 523.83 |
| Harga / Buku (P/B) | 1.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Mar 2026 |
| Margin Keuntungan | 3,711.54% |
| Margin Operasi (TTM) | -68,075.00% |
| EPS Cair (TTM) | 3.46 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -99.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.57% |
| Nisbah Semasa (MRQ) | 0.370 |
| Aliran Tunai Operasi (OCF TTM) | -22.03 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -19.74 M |
| Pulangan Atas Aset (ROA TTM) | -49.81% |
| Pulangan Atas Ekuiti (ROE TTM) | 644.12% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | PAVmed Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.38 |
|
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 22.22% |
| % Dimiliki oleh Institusi | 7.05% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Byrne Asset Management Llc | 31 Dec 2025 | 126,400 |
| First Manhattan Co. Llc. | 31 Dec 2025 | 23,801 |
| Xml Financial, Llc | 31 Dec 2025 | 336 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities |
| 21 Jan 2026 | Pengumuman | Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® |
| 30 Dec 2025 | Pengumuman | PAVmed Announces Reverse Stock Split |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |